Propionyl-L-carnitine

Many readers are interested in the right subject: the five overall reasons to use propionyl-L-carnitine. Our manufacturer is pleased to report that we have already conducted a study of current research on the subject that will fascinate you. We will give you a wide range of answers based on the latest medical reports, advanced research papers, and sample survey information. Keep repeating to find out more.

As an amino acid supplement, Propionyl-L-Carnitine powder is comparable to carnitine supplements, but with significantly more effective and potent qualities. Often it is recommended that 1, 5 to 4 grams of the powder be ingested 30-45 minutes prior to exercise and mixed with a spoon for 15-30 seconds to fully resolve.

Propionyl-L-carnitine

Glycine Propionyl-L-Carnitine HCl, Glycine Propionyl-L-Carnitine HCl, Propionyl-L-Carnitine, LPC, PLC, Propionyl-L-Carnitine, Propionylcarnitine.

Determination.

Propionyl-L-carnitine is considered a naturally occurring amino acid in the body. Amino acids are considered the building blocks of proteins; L-carnitine and acetyl-L-carnitine are still considered amino acids and are chemically related to propionyl-L-carnitine. In fact, the body can convert L-carnitine to propionyl-L-carnitine and acetyl-L-carnitine. However, no one knows if the superior properties of carnitine are considered interchangeable. Until we know more, one should not replace carnitine with another form.

Propionyl-L-carnitine is used to cure legs with leg pain (claudition intermittent) as a result of low blood flow (peripheral vascular disease, PVD); PVD is often caused by diabetes or “atherosclerosis” (atherosclerosis). Propionyl-L-carnitine is still used to cure congestive heart failure (CHF).

Men with sexual performance problems (e.g., erectile dysfunction) may use propionyl-L-carnitine in combination with prescription products as a result of diabetes or poor blood circulation. Older men with signs of low testosterone levels may use propionyl-L-carnitine in combination with acetyl-L-carnitine.

The propionyl-L-carnitine/acetyl-L-carnitine combination is still used to cure acquired lethal syndrome (CVS).

Medical staff need intravenous (IV) propionyl-L-carnitine to heal interrupted PVD and croadication; to improve wound healing in persons with PVD; and to treat heart conditions including congestive heart failure and chest pain (angina pectoris). To cure heart conditions including congestive heart failure and chest pain (angina pectoris).

Usage.

Propionyl-L-carnitine helps the body produce energy. It is important for heart function, muscle movement, and many other bodily processes. It also helps stimulate blood circulation.

Use and Effectiveness

Effective in

  • Circulatory disturbances (peripheral vascular disease) causing legs to walk (claudication is intermittent). Propionyl-L-carnitine, taken orally or intravenously, helps those with severe legs to walk further than they otherwise would. However, propionyl-L-carnitine may not help with non-cormore peripheral vascular disease.
  • heart failure (CHD). Propionyl-L-carnitine appears to improve cardiac function and exercise tolerance in people without moderate congestive heart failure.
  • Signs of “male menopause,” treatment of low testosterone due to aging. Propionyl-L-carnitine way intravenously intravenously combined with acetyl-L-carnitine in the direction of 6 months, clearly improves sexual potency and reduces depression and fatigue in old men. This composition works in the same way as testosterone.
  • Problems with sexual potency (e.g. erectile dysfunction) in diabetics. The combination of propionyl-L-carnitine and sildenafil (Viagra) is more effective than mere sildenafil.
  • Increased fibrotic fabric of the penis (Peyronie’s disease). An injectable combination of propionyl-L-carnitine with a product called verapamil appears to improve sexual potency, slow the progression of the disease, and reduce the need for surgery.
  • Chest pain (angina pectoris).
  • A type of heart disease called acquired ischemic heart disease in intravenous administration.

Insufficient evidence to evaluate operation.

  • Acquired lethargy syndrome (ALS). Developmental studies have shown that propionyl-L-carnitine can reduce joint fatigue in patients with ARS. Interestingly, the combination of propionyl-L-carnitine and acetyl-L-carnitine has been shown to be less effective than one of the two supplements.
  • Blood circulation problems caused by diabetes.
  • Other Conditions.

Characteristics of the Natural Medicines Group Scientific Evidence-Based Proof-Base Characteristics Based on the applicable scale: effective, effective, probably effective, probably effective, probably not effective, not effective, not evaluated (detailed description of each classification) .

Propionyl-L-carnitine

Slurry

Adverse effects

Propionyl-L-carnitine is not dangerous to most people when taken intravenously by mouth by a competent care provider. It can cause nausea, vomiting, abdominal pain, impotence, and chest pain (angina). May cause “suspicious” odors in urine, breath, and sweat.

Special precautions and warnings:

Pregnancy and Breastfeeding: Little is known about the use of propionyl-L-carnitine during pregnancy and breastfeeding. Stay on the harmless side and be reluctant to use it.

“Thyroid deficiency” (hypothyroidism): people fear that propionyl-L-carnitine hypothyroidism will get better or that the thyroid hormone cure will be ineffective. This is because the associated substance stops L-carnitine thyroid hormone. Do not take propionyl-L-carnitine if you have hypothyroidism.

Attacks: Some people with attacks report an increase in the number and severity of attacks after taking L-carnitine by mouth or intravenously (IV). There is a fear that this may occur with propionyl-L-carnitine because it is a similar chemical.

Interactions.

Interactions with Aachenocoumarol (Sintrom): there is little need to be aware of this configuration. Contact physician.

Akenocoumarol (Sintrom) is used to inhibit blood clotting. Propionyl-L-carnitine has the ability to enhance the effects of acenocoumarol (Sintrom).Building on the effects of Akenocoumarol (Sintrom) is its ability to slow blood clotting significantly and cause bruising and bleeding.Akenocoumarol (Sintrom) is used to inhibit blood clotting. Sintrom) dosage can be modified.

Interactions with Warfarin (Coumadin): There is little to note in this composition. Contact your physician for medical suggestions.

Warfarin (Coumadin) is used to inhibit blood clotting. Propionyl-L-carnitine can increase the function of warfarin (Coumadin) and increase the risk of bruising and bleeding. It is imperative that blood be checked regularly. Warfarin (Coumadin) dosage can be changed.

Dosage.

Scientific studies have investigated the following doses

  • With blood vessels: 500-1500 mg propionyl-L-carnitine twice daily.
  • For heart failure and chest pain due to problems with blood circulation (chronic angina pectoris): a dose of 500 mg propionyl-L-carnitine three times a day.
  • For signs of senility caused by insufficient testosterone: used doses of 2 g acetyl-L-carnitine and 2 g propionyl-L-carnitine.
  • For ED (erectile dysfunction): 2 g propionyl-L-carnitine in combination with 50 mg sildenafil (Viagra) twice a week was used.
  • For Peyronie’s disease: 2 g propionyl-L-carnitine daily combined with an injection with verapamil drug.
  • For vascular and cardiac disorders: the medical staff delivers propionyl-L-carnitine intravenously (via injection).

Propionyl-L-carnitine

PICTURE.

Propionyl-L-carnitine

Bad Mistakes and Their Bites

Propionyl-L-carnitine

Sexual killers

Propionyl-L-carnitine

Cancer tumors

Propionyl-L-carnitine

Multiple sclerosis

Propionyl-L-carnitine

Adult skin problems

Propionyl-L-carnitine

Habit of turning teeth

Propionyl-L-carnitine

Diabetes in 10 minutes

Propionyl-L-carnitine

Erectile dysfunction

Propionyl-L-carnitine

Diabetes mellitus such as diabetes 2 Warning Signs

Propionyl-L-carnitine

Health Benefits of Sex

Propionyl-L-carnitine

Scalp, hair, nails

Propionyl-L-carnitine

Symptoms of ADHD in Children?

Depends on

Healthy Heart Source
  • Drawing Psoriasis Can Affect Your Heart
  • Diagnosing Hypertrophic Cardiomyopathy
  • Practice in HCM: How to Sweat Safely
Selected Centers
  • What’s the Best PSA Procedure for You?
  • Understanding the Biology
  • 10 Things People With Depression Pursue That You Know
Wellness Solutions from Your Sponsor
  • Treating MS Without the Sting
  • Your Baby and covid-19

Wellness Solutions from Your Sponsor

  • Penis is curved with erection
  • Can I have CAD?
  • Pulse Vent Finger
  • HR+, HER2-MBC Treatments
  • Fed up with Lou?
  • Living with Cancer

Review 14.06.2021
Recommendations

12761 Benvenga S, Amato A, Calvani M, Trimarchi F. Effect of carnitine on thyroid hormone exposure.Ann n y Acad Sci 2004; 1033: 158-67. view abstract

Amico-Roxas M, Caruso A, Cutuli VM, et al. Inhibitory effect of propionyl-L-carnitine on stimulus-induced plasma expansion in mice. Drugs Exp Clin Res 1993; 19:213-7. view abstract

Anand I, Chandrashekhan Y, The Giuli F, et al. Acute and acquired effects of propionyl-L-carnitine on hemodynamics, physiological capacity and hormones in patients with congestive heart failure. Cardiovascular Means, 1998; 12: 291-9. view abstract

Anon. Carnitor (Levocarnitine) Package Leaflet. Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD. 1999 December.

Bachmann Hu, Hoffmann A. Interaction of L-carnitine supplementation with oral anticoagulant adenomas.Swiss Med Wly 2004; 134: 385.

Bardich-Crovo P., Toole J., Hendricks K. W. et al. Vigor of adefovir dipivoxil (9- [2- [2-(bispivalyoxymethyl)-phosphonylmethoxyethyl]adenine) against human immunodeficiency virus (HIV) microorganisms in HIV-infected patients, Protection and pharmacokinetics. j Infect Dis 1997; 176:406-13. bekijk Summary.

See also  Synchronized Cardioversion

Bartels GL, Remme WJ, Den Hartog FR, et al. Complementary anti-ischemic effects of long-term use of L-propionylcarnitine in angina pectoris patients receiving classical anti-vascular therapy. Cardiovascular Substances Ther 1995; 9: 749-53. bekijk samenvatting.

Bartels GL, Remme WJ, Holwerda KJ, Kruijssen DA, Kruijssen J. Eur Heart J 1996; 17: 414-20. bekijk summary.

Bartels GL, Remme WJ, Pillay M, et al. Rapid improvement in cardiac function with intravenous L-propionylcarnitine in humans. J Cardiovasc Pharmacol 1992; 20: 157-64.

Bartels GL, Remme WJ, Pillay M, et al. Effect of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris. Am J Cardiol 1994; 74:125-30.

Spirit EP. Pivalaat-Genererende Prodrugs en Carnitine Homeostase Bij de Mens. Pharmacol ed. 2002; 54: 589-98. Bekijk Summary.

Brevetti G, Deem S, Lambert D, et al. European multicenter study of propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 1999; 34: 1618-24. bekijk samenvatting.

Brevetti G, Perna S, Sabba S, et al. Effecten Van Propionyl-L-carnitine Op de Kwaliteit van leven bij claudicatio intermittens. Am J Cardiol 1997; 79: 777-80. Bekijk samenvatting.

Brevetti G, Perna S, Sabba S, et al. Propionyl-L-carnitine in Claudicatio intermittens: a double-blind, placebo-controlled, dose-titrated, multicenter study. J Am Coll Cardiol 1995; 26: 1411-6. bekijk samenvatting.

Brevetti G, Perna S, Sabba S, et al. Benefits of L-propionylcarnitine and L-carnitine in improving fermentability in patients with peripheral vascular disease: an acute intravenous double-blind crossover study.Eur Heart J 1992; 13: 251-5. Bekijk Summary.

Campos I, Arenas J. Muscle CarnitineDeficiëntieGeassocieerd met Zidovudine-GeïnduceerdeMitochondriale Myopathie. Ann Neurol 1994; 36:68 0-1. Show summary.

Caponnetto S., Canale S., Masperone MA, et al. Efficacy of healing with L-propionylcarnitine in patients with nonfunctioning left ventricle. Eur Heart J 1994; 15:1267-73. Bekijk Summary.

Caruso A, Coutuli VM, De Bernardis E, et al. Protective effect of propionyl-L-carnitine on PAF-induced rat paw edema. Pharmacol Res 1995; 31:67-72.

Castro-Gago M, Eiris-Panal J, Novo Rodriguez MI, et al. Serum carnatine levels in epileptic children during and after treatment with valproic acid, carbamazepine, and phenobarbital.J Child Neurol 1998; 13: 546-9. abstract.

Cavallini G, Biagiotti G, Koverech A, Vitali G. Orale propionyl-l-carnitine Within verapamil in the treatment of progressive and persistent disease of Peyronie’s. Bju int 2002; 89: 895-900. view abstract

Cavallini G, Caracciolo S, Vitali G, et al. Urology 2004; 63: 641-6. view abstract

Cherchi A, Lai C, Onnis E, et al. Propionylcarnitine in dimensional angina pectoris. 1990; Cardiovascular Compounds; 4: 481-6. Show summary.

Chiddo A, Gaglione A, Musci S, et al. Hemodynamic studies of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function. Ceredias Preparation 1991. 5 Suppl 1: 107-11. overview.

Coulter DL. carnitine, valproic acid and toxicity. J Child Neurol 1991; 6: 7-14. show distracting.

Coulter DL. Prevention of recurrent hepatotoxicity by Valcat and Carnitine monotherapy. ann Neurol 1988; 24: 301.

Dal Lago A, The Martini D, Flore R et al. Effects of propionyl-L-carnitine on peripheral arterial obliteration disease of the lower extremities: a double-blind clinical study.Drugs Exp Clin Res 1999; 25: 29-36. view abstract

Dalakas MC, Leon-Monzon ME, Bernardini I, et al. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid savings.Ann Neurol 1994; 35:482-7. view abstract

Vivo DC, Bohan TP, Coulter DL, et al. Jourdiction 1998; 39: 1216-25. view abstract

Deeks SG, Collier A, Lalezari J, et al. Protection and efficacy of Adefovir Dipivoxil, an immunocompromised microorganism opiton in the general population (HIV), HIV-infected mature adults: randomized double-bobbed-bo – blind – brand blind blind blind blind

Evans AM, Fornasini G. Pharmacokinetics of L-carnitine.Clin Pharmacokinet 2003; 42:941-67. abstract view.

Ferrari R, Juli F. The propionyl-L-carnitine project: a different view of healing heart deficiency. J Card Fail 1997; 3: 217-24. view abstract

Freeman JM, Vining Pge, Kosts S, Singhi P. Double-blind crossover study.Pediatrics 1994; 93:893-5. view abstract

Gentile V, Vicini P, Prigiotti G, et al. Curr Med Res Opin 2004; 20: 1377-84. view abstract

Georgala S, Schulpis KH, Georgala S, Michas T. L-carnitine supplementation in patients with cystic acne treated with isotretinoin. J EUR Acad Dermatol Venereol 1999; 13: 205-9. Show summary.

Georges B, Galland S, Rigaud S, et al. Appropriate effects of L-carnitine on C2C12 myoblasts. Interaction with zidovudine. Biochem Pharmacol 2003; 65:1483-8. view abstract

Heuberger W, Berardi S, Jackie E, et al. Excessive urinary excretion of carnitine in patients treated with cisplatin. Eur J Clin Pharmacol 1998; 54:503-8. view abstract

Hiatt WR, Regesteiner JG, Kreger MA, et al. Propionyl-L-carnitine improves exercise capacity and active status in croad or croad patients. Am J Med 2001; 110: 616-22. view abstract

Hirose S, Mitsudome A, Yasumotions, et al. Valproic acid therapy does not decrease carnitine levels in healthy children Pediatrics 1998; 101:E9 (summary). Show summary.

Holm E, Grether J, Jacobson SE, et al. Carnitine deficiency induced by treatment with pivampicillin and pivmecillinam. Lancet 1989; 2: 469-73. abstract.

Hag J, McGraw CA, Bates SR, et al. Decreased serum carnitine concentrations in response to anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in pediatric patients. Journal Paediar 1991; 119: 799-802. abstract.

Kahn J, Lagakos S, Wolfson M, et al. Efficacy and protection of Adefovir Dipivoxil in antiretroviral therapy. J Am Med Assoc 1999; 282:2305-12. view abstract

Krahenbuhl S, Reichen J. Carnitine metabolism in patients with cerebral liver disease. Liver 1997; 25: 148-53. view abstract.

Krahenbuhl S. Carnitine metabolism in posterior weak liver disease. life Sci 1996; 59: 1579-99. view abstract.

Kurul S., Dirik E., Iskan A. Importance of serum carnitine duration oxcarbazepine and carbamazepine monotherapy in boys with epilepsy. J Child Neurol 2003; 18: 552-4. summary View Abstract

Leiker M. F., Green S., Bhuyan A. K., Schuster S. Isotretinoin and serum lipids: studies of fatty acids, apolipoproteins and intermediary metabolism. Br J Dermatol 1987; 117:203-6. view abstract

Mancini M, Lengo F, Linguetti M, et al. Arzneimittelforschung 1992; 42:1101-4. abstract.

Marthaler NP, Visarius T, Kupfer A, Lauterburg BH. Structure of urinary carnitine cost during Ifosfamide chemotherapy.Cancer CheTher Pharmacol 1999; 44: 170-2. Show summary.

Martinez E, Domingo P, Roca-Cusachs A. Potential impact of acinocoumarol by l-carnitine support. J Mid 1993; 233: 94.

Mintz M. Carnitine in human immunodeficiency microorganism infection pattern 1 infection/ acquired immune deficiency syndrome. j Child Neurol 1995; 10: S40-4. view abstract

Noble S, Gore KL. Adefovir Dipivoxil. drugs 1999; 58: 479-87. abstract view.

Opala G, Winter S, Vance C, et al. Effect of valproic acid on plasma carnitine levels. Am J Dis Child 1991; 145: 999-1001. abstract view.

Persico G, Amato B, Aprea G, et al. Initial effect of intravenous L-propionylcarnitine on ulcerative trophic loosening of the lower extremities in patients with arterial injury: a controlled randomized study. Drugs Exp Clin Res 1995; 21:187-98. view abstract

Raskind JY, El-Chaar G M. Role of carnitine supplementation during treatment with valproic acid. Ann Pharmacother 2000; 34: 630-8. view abstract

cj. kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. ann n y Acad Sci 2004; 1033:30-41. view abstract

Riva R, Albani F, Gobbi G, et al. Grapevine Disease 1993; 34: 184-7. view abstract

Schlenzig JS, Charpentier C, Rabier D, et al. L-Carnitine: a method to inhibit the cytotoxicity of Ifosfamide? Eur J Pediar 1995; 154: 686-7. view abstract

Sekas G, Paul HS. Pyramondemia and carnitine deficiency in patients treated with sulfadiazine and pyrimethamine. Am J Med 1993; 95:112-3. view abstract

Shapira Y, Gutman A. Muscle carnitine deficiency in patients treated with valproic acid.J Pediatrics 1991; 118:646-9. view abstract

Siliprandi N, Di Lisa F, Menabo R. Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism. Cardiovascular Agents Ther 1991; 5 Suppl 1: 11-5. view abstract

Stanley K. Carnitine deficiency disorders.Ann n y Acad Sci 2004; 1033:42-51. Show Distracted.

Tom H, Carter P. E., Cole G. F. etal. Ammonia and Carnitine concentrations in children treated with sodium valcate compared to other anticonvulsant products. Dev Med Child Neurol 1991; 33: 795-802. Show summary Abstract.

Tsoko M, Beauseigneur F, Gresti J, et al. Improved vitality against fatty acid oxidation in the liver of L-carnitine depleted rats in favor of D-carnitine and gamma-butyrothin hydroxylase inhibitors.Biochem Pharmacol 1995; 49: 1403-10. abstract.

See also  15 Healthy Late Night Fast Food - TSMP Medical Blog

From Nuwe JP. Carnitine depletion during valproic acid treatment.Int J Vitam Nutr Res 1995; 65: 211-4. abstract view.

Vance KK, Vance H, Winter SK, et al. Ann Neurol 1989; 26: 456.

Vermeulen RC, Scholte HR. a randomized, labeled, randomized study of acetyl and propionylcarnitine in stroke syndromes disclosed. psychosom Med 2004; 66: 276-82. display abstract.

Winter SC, Szabo-Aczel S, Curry CJR, et al. PlasmaCarnitine deficiency: a clinical study of 51 pediatric patients. Am J Dis Child 1987; 141: 660-5. view abstract

Weissman LR, Brogden RN. propionyl-L-carnitine. 1998 Substance Aging; 12: 243-8; reviewed 249-50. abstract view.

Wu X, Huang W, Prasad PD, et al. Activity characteristics and tissue dispersion pattern set of organic cation/carnitine transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482-92. abstract view.

Zelnik N, Fridkis I, Gruener N. Carnitine and antiepileptic drug reduction: does it cause problems or coexistence? Acta Paediar 1995; 84: 93-5. abstract view.

Five Noble Global Reasons to Use Propionyl-L-Carnitine

 propionyl-l-carnitine

Propionyl-L-carnitine is considered a naturally occurring amino acid in the body, and as we all know, amino acids are the building blocks of proteins; L-carnitine and acetyl-L-carnitine are chemically related to propionyl-L-carnitine amino acids and are considered to be chemically related to propionyl-L-carnitine. However, with all this knowledge at hand, it is unclear if the superior properties of carnitine can be considered interchangeable. It is recommended that one not switch from one form of carnitine to another until supporting research has been analyzed.

As an amino acid supplement, Propionyl-L-Carnitine powder is comparable to carnitine supplements, but with significantly more effective and potent qualities. Often it is recommended that 1, 5 to 4 grams of the powder be ingested 30-45 minutes prior to exercise and mixed with a spoon for 15-30 seconds to fully resolve.

More on this later, but in general, this supplement helps your body produce the energy it needs for its daily needs; the energy produced by GPLC, or glycine propionyl-L-carnitine, is often generated by the so-called “sugar high” helps prevent energy crashes and is essential for athletes and stress-free individuals.

In addition, GPLC is known to increase blood supply to the heart and helps transport fatty acids to the organs for conversion into energy.

Propionyl-L-Carnitine L-Arginine and Niacin

In the field of sexual medicine, propionyl-L-carnitine, L-arginine, and niacin suggest a nutrient approach to erectile dysfunction. In a group of 54 people aged 35 to 75 who participated in an ED clinic at the Sapienza Institute in Rome and used virtually no other means to cure ED, scientists found the effects of three months of supplementation with propionyl-L-carnitine, L-arginine, and niacin on sexual performance. [Gianvrilli D, Lauretta R, Dato C, Graziadio C, Pozza C, De Larichaudy J, Giannetta E, Isidori AM, Lenzi A. Propionyl-L-carnitine dysfunction. andrologia 2011 Oct 4. doi: 10. 1111/j. 1439-0272. 2011. 01234

Propionyl-L-Carnitine in EDS

This leads logically to the upcoming section L-L-Carnitine and Erectile Dysfunction. Many studies have shown that both carnitine and testosterone, such as testosterone, increased prostate size, but carnitine did not. Another double-blind, placebo-controlled study showed that 2 milligrams of propionyl-L-carnitine per day increased the efficacy of sildenafil (Viagra) in 40 diabetic men who had not previously responded to other medications at least 8(x) (xx).

Large supplements a cheerful precedent: men with sexual performance problems due to diabetes or poor blood circulation may turn to propionyl-L-carnitine in combination with prescription medications. Older men showing signs of low testosterone may use it in combination with acetyl-L-carnitine.

Superior Properties of Propionyl-L-Carnitine

For all of these (and apart from the aforementioned factor erectile dysfunction), propionyl-L-carnitine helps the body produce energy and is important for heart function, muscle movement, and many other body processes. Some health experts believe it helps improve blood circulation.

It plays an important role in energy production by transporting fatty acids to the mitochondria of your cells. Thereby, the mitochondria act as the engine of your cells, burning these fats to produce the needed energy (xx)(xxx)(xxx)(xxx)(xxx)(xxx).

A nice antecedent: 98% of L-carnitine POORRAAD is found in muscle, with traces in the liver and blood.

Several recent studies have shown that there are benefits of various forms of carnitine. This can be used in many diseases including heart disease and brain diseases (X)(XX).

  • Weight Loss. In paper and study, the use of L-carnitine as a weight loss supplement is logical. It is reasonable to assume that it enhances the ability to burn fat and lose weight because it helps bring more fatty acids into the cells for energy burning. However, the human body is very complex and the results of both human and animal studies vary (x)(xx)(xxx)(xxx)(xxxx)(xxxx),
  • Brain function. Some animal studies have shown that acetyl-L-carnitine (ALCAR), a component of acetyl, helps prevent the age-related decline in intelligence, and that “markers of learning” can improve (xx)(xxx). On the other hand, studies have shown that daily administration of acetyl-L-carnitine can help (xx)(xxx)(xxx)(xxx) the downward shifts in brain function associated with Alzheimer’s disease and other brain disorders. This configuration has shown similar superior qualities for joint brain function in older adults who do not have Alzheimer’s disease or other similar brain diseases. In certain cases, this configuration has the potential to protect the brain from cellular damage, but additional research is needed on its long-term advantage for healthy individuals.
  • Heart Health. Several studies have shown the potential to lower blood pressure and inflammation associated with heart disease (X)(XX); L-carnitine has already been associated with improvements in patients with non-interfering heart disease, including coronary heart disease and acquired heart failure (X)(XX).
  • Athletic Performance – Evidence is mixed regarding the actual effects of L-carnitine on athletic performance. However, there are many studies indicating that there are no seriously superior properties associated with huge or longer doses (x)(xx)(xx)(xxx). These needs include recovery, muscle supply, endurance, muscle soreness, and red blood cell production.
  • Diabetes Type 2-L-Carnitine still has the ability to reduce signs of Diabetes 2 and related risk moments (x)(xx)(xx)(xxx). by increasing an important enzyme called AMPK, which has the ability to fight diabetes and improve the body’s ability to use carbohydrates (x) X).

Propionyl-L-carnitine agents

Standard doses of L-carnitine vary from 500 to 2000 milligrams per day. However, dosage advice varies from study to study, with a maximum of 2000 milligrams (or 2 grams) per day being considered harmless and effective in the long term.

A large suppleate is advised to 500 milligrams (about 1/5 of a teaspoon) of this dietary supplement, 1 to 4 teaspoons per day, or in consultation with a physician director. Our product L-Carnitine can be found here.

Lows.

Propionyl-L-carnitine is considered a naturally occurring amino acid in the body, and as we all know, amino acids are the building blocks of proteins. l-carnitine and carnitine acetyl L are chemically related to propionyl-L-carnitine considered an amino acid. However, with all this knowledge at hand, it is unclear if the superior properties of carnitine can be considered interchangeable. It is recommended that one not switch from one form of carnitine to another until supporting research has been analyzed.

As an amino acid supplement, Propionyl-L-Carnitine powder is comparable to carnitine supplements, but with significantly more effective and potent qualities. Often it is recommended that 1, 5 to 4 grams of the powder be ingested 30-45 minutes prior to exercise and mixed with a spoon for 15-30 seconds to fully resolve.

In general, this supplement helps your body produce the energy needed for daily needs; the energy produced by GPLC, or glycine propionyl-L-carnitine, helps prevent the energy crash that often occurs with the so-called “sugar high.” essential for athletes and stress-free individuals.

In addition, GPLC is known to increase blood supply to the heart and helps transport fatty acids to the organs for conversion into energy.

These claims have not been evaluated by the Food and Drug Administration and these products are not intended to diagnose, treat, cure, or prevent disease.

About Us

Family Medicine

Family MedicineIn 2024 our team of doctors and nurses provide a comprehensive range of family planning services. Our doctors have expertise in antenatal care, preconception planning, and STD checks. Contraceptive advice including Mirena and Implanon insertion is available.

  • Early detection of illness;
  • Family planning;
  • Promotion of healthy lifestyle;
  • Skin cancer checks;
  • Sports injuries;
  • Weight reduction;
  • Workers compensation and third party.

  • Children's Health

    Children's HealthBaby Weighing Service. Babies can be booked with our Nurse for weighing, a doctors appointment is not required to use this service. Contact reception for a appointment to have your baby weighed.

    Immunisations. At Tuggeranong Square children's immunisation is regarded an important part of your childs health care. Our doctors take immunising children very seriously. and to ensure all children are immunised Tuggeranong Square Medical Practice doctors BULK BILL for all childhood immunisations. Tuggeranong Square Medical Practice also ensures the Practice Nursing Staff are highly trained in childhood immunisations.


    Women's Health

    Women's HealthOur practice is dedicated to treating a wide spectrum of women’s health concerns. We offer pre-natal, antenatal and postnatal care, contraceptive options, pap screening, and preventative health care advice. We provide assistance, advice and support through all stages of life, recognising the many issues many women may face from adolescence through to the peri and post-menopausal period.

    • Cervical Screening tests;
    • Reproductive health. Including Mirena and Implanon insertion;
    • Shared antenatal care.

    Men's Health

    Men's HealthWe encourage men to present routinely to their GP to discuss all aspects of their health. We provide comprehensive advice and support for men to address the prevention and management of various health conditions. This may include assessments for cardiovascular risk, diabetes, cancer prevention, mental health assessments, STD screening, sports injuries and the importance of sleep as it relates to other areas of health.


    • Preventative Healthcare. Including cardiovascular screening, mental health and cancer checks;
    • Prostate examination.
Alex Koliada, PhD

Alex Koliada, PhD

Alex Koliada, PhD, is a well-known doctor. He is famous for his studies of ageing, genetics and other medical conditions. He works at the Institute of Food Biotechnology and Genomics NAS of Ukraine. His scientific researches are printed by the most reputable international magazines. Some of his works are: Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population [BiomedCentral.com]; Mating status affects Drosophila lifespan, metabolism and antioxidant system [Science Direct]; Anise Hyssop Agastache foeniculum Increases Lifespan, Stress Resistance, and Metabolism by Affecting Free Radical Processes in Drosophila [Frontiersin].
View All Articles